Sign in
ORIC Stock Price, Chart, Stats & News
ORIC Pharmaceuticals, Inc.
Save
ORIC Pharmaceuticals, Inc. (ORIC) does not currently pay a dividend.
1.15B
Market cap
–
Current P/E
–
Forward P/E
ORIC chart
1M
3M
1Y
5Y
Loading chart...
Fundamentals
Gross margin | – |
Operating margin | – |
Pretax margin | – |
Net margin | – |
Effective tax rate | – |
ROA | -31.50% |
ROE | -38.79% |
D/E | 0.03x |
Interest coverage ratio | – |
ORIC valuation
P/E | – |
P/S | – |
P/B | 2.75x |
P/CF | -9.52x |
P/FCF | -10.80x |
P/OCF | -9.52x |
PEG | -0.67x |
EV multiple | -9.31x |
About
ORIC Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical firm dedicated to discovering and advancing innovative treatments for cancer patients across the United States. The company's pipeline includes several key clinical-stage drug candidates. ORIC-533 is an oral small molecule designed to inhibit CD73, addressing resistance to both chemotherapy and immunotherapy.
Similar securities
Based on sector and market capitalization
Report issue